Table 3.
Subgroup analysis of intima-media thickening and atherosclerotic plaques in systemic sclerosis and systemic lupus erythematosus patients with cardiovascular disease
| Subgroup of SSc and SLE patients with cardiovascular disease | Pathologic IMT (any definition) |
Atherosclerotic plaque |
||||
|---|---|---|---|---|---|---|
| Carotid and/or femoral artery plaque | Only carotid artery plaque | Only femoral artery plaque | Coexistent carotid and femoral artery plaque | |||
| SSc patients with |
Arterial hypertension (n = 45) |
16 (35.6%) |
38 (84.4%) |
7 (15.6%) |
5 (11.1%) |
26 (57.8%) |
| Pulmonary hypertension (n = 17) |
6 (35.3%) |
15 (88.2%) |
0 (0%) |
2 (11.8%) |
13 (76.5%) |
|
| Coronary heart disease (n = 10) |
2 (20%) |
8 (80%) |
0 (0%) |
0 (0%) |
8 (80%) |
|
| Peripheral artery vessel disease (n = 5) |
2 (40%) |
4 (80%) |
1 (20%) |
1 (20%) |
2 (40%) |
|
| SLE patients with | Arterial hypertension (n = 56) |
15 (26.8%) |
39 (69.6%) |
10 (17.9%) |
9 (16.1%) |
20 (35.7%) |
| Pulmonary hypertension (n = 3) |
1 (33.3%) |
3 (100%) |
1 (33.3%) |
1 (33.3%) |
1 (33.3%) |
|
| Coronary heart disease (n = 9) |
5 (55.6%) |
9 (100%) |
1 (11.1%) |
0 (0%) |
8 (88.9%) |
|
| Peripheral artery vessel disease (n = 2) | 1 (50%) | 2 (100%) | 0 (0%) | 0 (0%) | 2 (100%) | |
Values presented as number (percentage) of patients with pathologic intima-media thickness and carotid or femoral artery plaque.
IMT, intima-media thickness; SLE, systemic lupus erythematosus; SSc, systemic sclerosis.